Month: February 2026

Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

Management to host conference call at 8:00 AM Eastern time on Thursday, February 12, 2026Toronto, Ontario and Chicago, Illinois--(Newsfile Corp....

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026

Financials for Third Quarter of Fiscal Year 2026 Ended December 31, 2025 will be released on Tuesday, February 17, 2026Northvale,...

Rythmia Life Advancement Center Surpasses $1 Million in Scholarship Awards, Sending 156 Recipients to Medically Licensed Ayahuasca Retreat

Need-based program removes financial barriers to plant medicine healing, awarding over $1,008,105 in full retreat scholarships to date. LOS ANGELES,...

Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors

Burlington, Ontario--(Newsfile Corp. - February 11, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian...

error: Content is protected !!